Earnings Preview: TVTX to Report Financial Results Post-market on May 01

Moomoo NewsApr 25 21:00 ET

Press Release: Travere Therapeutics to Report First Quarter 2025 Financial Results

Dow JonesApr 24 16:59 ET

Travere Therapeutics, Inc. (NASDAQ:TVTX) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Simply Wall StApr 13 08:36 ET

Scotiabank Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Cuts Target Price to $30

Moomoo NewsApr 12 02:32 ET · Ratings

CCORF Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $47

Moomoo NewsApr 11 02:31 ET · Ratings

Guggenheim Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $47

Moomoo NewsApr 11 02:31 ET · Ratings